TissueGen to Showcase ELUTE® Fiber for Advanced Drug Delivery, Nerve Regeneration and Tissue Engineering at TERMIS World Congress

01 Sep TissueGen to Showcase ELUTE® Fiber for Advanced Drug Delivery, Nerve Regeneration and Tissue Engineering at TERMIS World Congress

WHO: TissueGen® Inc., developer of ELUTE® fiber, a groundbreaking biodegradable fiber format for advanced drug delivery, nerve regeneration, and tissue engineering.

WHAT: The theme for this year’s TERMIS World Congress is “Past, Present Future: The Evolution of Regenerative Medicine,” reflecting the impact of tissue engineering throughout the past two decades, and focusing on the future. To this end, the 2015 scientific program will focus on the innovative technologies focused in regenerative medicine. TissueGen will be exhibiting its ELUTE fiber in Booth #202.

Available in in pharmaceutical and growth factor formats, ELUTE is ideal for a broad range of regenerative medicine and tissue engineering applications such as:

  • – 3-dimensional tissue scaffolds
  • – Small diameter vascular grafts
  • – Spinal cord repair
  • – Peripheral nerve regeneration
  • – Controlled drug release
  • – Directed tissue growth

ELUTE fibers can directly replace standard fibers used in biodegradable textiles currently on the market and provide significantly improved clinical outcomes by delivering therapeutic agents directly at the site of the implant. By delivering drugs at the site of implantation, ELUTE fibers enable medical devices to guide the body’s healing and regenerative processes.

WHERE:
TERMIS World Congress 2015
Booth 202
Boston Marriott Copley Place
Boston, MA

WHEN: TERMIS World Congress will take place September 8-11, 2015.

 

To schedule a briefing, please contact Jordan Bouclin at Jordan.bouclin@svmpr.com or (401)490-9700.

 

About TissueGen

TissueGen® Inc. has more than four decades of cumulative experience in extruding biodegradable polymer fibers with broad drug delivery capabilities well-suited for advanced drug delivery, nerve regeneration, and tissue engineering. TissueGen offers the medical market a portfolio of issued patents on unique drug delivery technology with the capability to incorporate and elute a broad range of biologically derived therapeutics and standard pharmaceuticals in hydrophobic, biodegradable polymeric fibers or tubes for sustained therapeutic release. For more information, please visit www.tissuegen.com.

 

# # #

 

For more information contact:

Jordan Bouclin
SVM Public Relations
401-490-9700
jordan.bouclin@svmpr.com

No Comments

Sorry, the comment form is closed at this time.